Human Salivary Amylase From Lee Biosolutions, Inc
Sept 13th, 2007, ST. LOUIS -- Lee Biosolutions is now providing Human Salivary Amylase to clinical researchers worldwide. Human salivary amylase (http://www.leebio.com/products/details.html?uid=17), also called ptyalin, is an enzyme produced by the salivary glands that initiates carbohydrate digestion in the mouth and continues in the body of the stomach after food and saliva has been swallowed.
Lee Biosolutions' extensive human donor program allows them to process over 500 liters of human saliva per year for their human salivary amylase production requirements. Their high purity human salivary amylase enzyme has already been qualified by major IVD manufacturers worldwide.
According to Lee Biosolutions President Burton Lee, human salivary amylase is one of a number of new products the company is introducing in 2007.
"We operate with one ear constantly tuned to the research community," Lee said. "This helps us stay on top of the latest research being conducted, and gives us the information we need to stay ahead of their demands."
Human Salivary Amylase enzyme is the only enzyme in saliva capable of degrading oligosaccharides, which are used by the oral microflora for nutritional purposes. Because human salivary amylase can act anywhere on the substrate, human alpha-amylase enzyme tends to be faster acting than beta-amylase enzyme.
Lee Biosolutions is also working with researchers around the world in regards to saliva based diagnostics and identifying specific biomarkers to cancers and systemic diseases that are found in saliva.
Lee Biosolutions is a leader in the biomarker industry, providing the quality products to clinical labs and researchers around the world, developing tomorrow's cures. The company has provided the materials used in a number of high profile biomarker studies. For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company's website at http://www.leebio.com
Lee Biosolutions' extensive human donor program allows them to process over 500 liters of human saliva per year for their human salivary amylase production requirements. Their high purity human salivary amylase enzyme has already been qualified by major IVD manufacturers worldwide.
According to Lee Biosolutions President Burton Lee, human salivary amylase is one of a number of new products the company is introducing in 2007.
"We operate with one ear constantly tuned to the research community," Lee said. "This helps us stay on top of the latest research being conducted, and gives us the information we need to stay ahead of their demands."
Human Salivary Amylase enzyme is the only enzyme in saliva capable of degrading oligosaccharides, which are used by the oral microflora for nutritional purposes. Because human salivary amylase can act anywhere on the substrate, human alpha-amylase enzyme tends to be faster acting than beta-amylase enzyme.
Lee Biosolutions is also working with researchers around the world in regards to saliva based diagnostics and identifying specific biomarkers to cancers and systemic diseases that are found in saliva.
Lee Biosolutions is a leader in the biomarker industry, providing the quality products to clinical labs and researchers around the world, developing tomorrow's cures. The company has provided the materials used in a number of high profile biomarker studies. For more information or to place an order, contact Lee Biosolutions at 314-968-1091, or visit the company's website at http://www.leebio.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.